Growing community of inventors

Halle-Zoersel, Belgium

Anne Simone Lesage

Average Co-Inventor Count = 3.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 51

Anne Simone LesageJohannes Wilhelmus Thuring (4 patents)Anne Simone LesageJosepha Eduarda Leysen (3 patents)Anne Simone LesageDidier Robert De Chaffoy De Courcelles (2 patents)Anne Simone LesageWei Zhuang (2 patents)Anne Simone LesageTheodorus Dinklo (2 patents)Anne Simone LesageMarcel Frans De Bruyn (2 patents)Anne Simone LesageTheodorus Dinklo (2 patents)Anne Simone LesageGregor James Macdonald (2 patents)Anne Simone LesageMarc Joris De Brabander (1 patent)Anne Simone LesageChristopher James Grantham (1 patent)Anne Simone LesageFrans Alfons Van Den Keybus (1 patent)Anne Simone LesageYves Emiel Van Roosbroeck (1 patent)Anne Simone LesageJames Edward Duffy (1 patent)Anne Simone LesageAnne Simone Lesage (3 patents)Johannes Wilhelmus ThuringJohannes Wilhelmus Thuring (9 patents)Josepha Eduarda LeysenJosepha Eduarda Leysen (6 patents)Didier Robert De Chaffoy De CourcellesDidier Robert De Chaffoy De Courcelles (8 patents)Wei ZhuangWei Zhuang (3 patents)Theodorus DinkloTheodorus Dinklo (2 patents)Marcel Frans De BruynMarcel Frans De Bruyn (3 patents)Theodorus DinkloTheodorus Dinklo (2 patents)Gregor James MacdonaldGregor James Macdonald (29 patents)Marc Joris De BrabanderMarc Joris De Brabander (7 patents)Christopher James GranthamChristopher James Grantham (1 patent)Frans Alfons Van Den KeybusFrans Alfons Van Den Keybus (7 patents)Yves Emiel Van RoosbroeckYves Emiel Van Roosbroeck (5 patents)James Edward DuffyJames Edward Duffy (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Janssen Pharmaceutica Nv (3 from 2,078 patents)


3 patents:

1. 6075046 - Use of nebivolol as an anti-atherogenic

2. 5955485 - Use of fused benzothiazoles as neuroprotectants

3. 5874461 - Use of Nebivolol as an anti-atherogenic

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/28/2025
Loading…